By Justyna Lisowska and Ming Wang, Genedata This content is brought to you by Genedata, a Danaher Operating Company. AI can narrow the combinatorial search space in oligonucleotide design, but faster predictions are not the same as biological insight. The constraint is the data. Literature and patent sources vary in experimental conditions, rarely report failed experiments, and often leave safety information incomplete.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Justyna Anna Lisowska
Making NGS Work For Analytical Development And QC Original
By Justyna Lisowska, Genedata This content is brought to you by Genedata, a Danaher Operating Company. NGS can act as a single multi-attribute method, covering identity, sequence integrity, genetic stability, biosafety, and adventitious agent detection that would otherwise take several assays. Regulatory support is growing, including recognition of NGS in the revised ICH Q5A(R2). Yet sequencing capacity is only part of the picture.
AI Agents: The Scientists' New Allies
By Joel Ottosson and Justyna Lisowska, PhD, Genedata This content is brought to you by Genedata, a Danaher Operating Company. Biopharma R&D is moving into a new phase shaped by intelligent AI agents that can reason, interact with data systems, and support complex scientific decisions. Their potential is enormous—from uncovering disease biology to shaping trial designs in real time—but readiness across the industry varies widely.
Precision Medicine In IMIDs - The Path To Improved Healthcare Outcomes
By Justyna Lisowska, Scientific Communications This content is brought to you by Genedata, a Danaher Operating Company. Precision medicine has transformed oncology by enabling therapies that directly target the molecular drivers of disease. That same potential is now emerging in immune‑mediated inflammatory diseases (IMIDs), a diverse group of more than 100 chronic conditions shaped by complex interactions between genetics, environment, and immune dysregulation.
Precision Medicine In IMIDs - The Path To Improved Healthcare Outcomes
Article | January 29, 2026 By Justyna Lisowska, Scientific Communications access the Article! Get unlimited access to: Trend and Thought Leadership Articles Case Studies & White Papers Extensive Product Database Members-Only Premium Content Welcome Back! Please Log In to Continue. X Enter your credentials below to log in. Not yet a member of Water Online? Subscribe today.
Latent Labs Claims ‘Push-Button’ Protein Design With 91-100% Hit Rates
London-based Latent Labs has launched what it calls a “frontier AI model” for protein binder design, claiming hit rates of 91-100% for macrocycles and 10-64% for mini-binders across seven therapeutic targets, a dramatic improvement over traditional drug discovery’s sub-1% success rates.
Novo Nordisk Foundation Brings World’s Most Powerful Computer To Nordics
Denmark’s €80m QuNorth project, co-led by the Novo Nordisk Foundation, launches most powerful quantum computer to advance drug discovery and broader scientific research across the Nordics. Denmark is positioning itself at the forefront of quantum-powered drug discovery with an €80m investment in what is billed as the world’s most powerful quantum computer.
Enabling Precision Medicine At Scale Through Digital Innovation And AI
AI is reshaping clinical trials by enabling precision medicine, accelerating patient stratification, optimizing trial design, and transforming complex data into actionable insights for faster, more effective drug development. (Shutterstock) Biopharmaceutical companies are operating at record levels of R&D activity with more than 23,000 drug candidates currently in development, including over 10,000 in clinical stages, according to Evaluate data.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Justyna Anna
Contact Justyna Anna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack